163 related articles for article (PubMed ID: 7647943)
41. Methotrexate and misoprostol to terminate early pregnancy.
Hausknecht RU
N Engl J Med; 1995 Aug; 333(9):537-40. PubMed ID: 7623901
[TBL] [Abstract][Full Text] [Related]
42. First-trimester pregnancy termination with 800 microg of vaginal misoprostol every 12 h.
Salakos N; Kountouris A; Botsis D; Rizos D; Gregoriou O; Detsis G; Creatsas G
Eur J Contracept Reprod Health Care; 2005 Dec; 10(4):249-54. PubMed ID: 16448952
[TBL] [Abstract][Full Text] [Related]
43. Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion.
Schaff EA; Fielding SL; Westhoff C
Contraception; 2001 Aug; 64(2):81-5. PubMed ID: 11704083
[TBL] [Abstract][Full Text] [Related]
44. Abortion induced with methotrexate and misoprostol: a comparison of various protocols.
Wiebe ER
Contraception; 1997 Mar; 55(3):159-63. PubMed ID: 9115004
[TBL] [Abstract][Full Text] [Related]
45. 25 mg or 50 mg of oral methotrexate followed by vaginal misoprostol 7 days after for early abortion: a randomized trial.
Carbonell Esteve JL; Varela L; Velazco A; Tanda R; Sánchez C
Gynecol Obstet Invest; 1999; 47(3):182-7. PubMed ID: 10087413
[TBL] [Abstract][Full Text] [Related]
46. The kinetics of serum hCG and progesterone in response to oral and vaginal administration of misoprostol during medical termination of early pregnancy.
Honkanen H; Ranta S; Ylikorkala O; Heikinheimo O
Hum Reprod; 2002 Sep; 17(9):2315-9. PubMed ID: 12202418
[TBL] [Abstract][Full Text] [Related]
47. [Assessment of efficacy and safety of medical treatment of non-viable first trimester pregnancy].
Zwierzchowska A; Głuszak M; Jabiry-Zieniewicz Z; Banaszek-Wysoczańska A; Dziadecki W; Barcz E
Ginekol Pol; 2012 Oct; 83(10):760-5. PubMed ID: 23383562
[TBL] [Abstract][Full Text] [Related]
48. The use of misoprostol for abortion at < or = 9 weeks' gestation.
Carbonell JL; Varela L; Velazco A; Fernández C; Sánchez C
Eur J Contracept Reprod Health Care; 1997 Sep; 2(3):181-5. PubMed ID: 9678090
[TBL] [Abstract][Full Text] [Related]
49. Feasibility and effectiveness of unintended pregnancy prevention with low-dose mifepristone combined with misoprostol before expected menstruation.
Li CL; Chen DJ; Deng YF; Song LP; Mo XT; Liu KJ
Hum Reprod; 2015 Dec; 30(12):2794-801. PubMed ID: 26405260
[TBL] [Abstract][Full Text] [Related]
50. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
Guest J; Chien PF; Thomson MA; Kosseim ML
BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
[TBL] [Abstract][Full Text] [Related]
51. Comparison of vaginal misoprostol and gemeprost as pre-treatment in first trimester pregnancy interruption.
Henry AM; Haukkamaa M
Br J Obstet Gynaecol; 1999 Jun; 106(6):540-3. PubMed ID: 10426610
[TBL] [Abstract][Full Text] [Related]
52. Cervical preparation for first trimester surgical abortion.
Kapp N; Lohr PA; Ngo TD; Hayes JL
Cochrane Database Syst Rev; 2010 Feb; (2):CD007207. PubMed ID: 20166091
[TBL] [Abstract][Full Text] [Related]
53. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
[TBL] [Abstract][Full Text] [Related]
54. A comparison of tamoxifen and misoprostol to misoprostol alone for early pregnancy termination.
Jain JK; Meckstroth KR; Park M; Mishell DR
Contraception; 1999 Dec; 60(6):353-6. PubMed ID: 10715370
[TBL] [Abstract][Full Text] [Related]
55. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
[TBL] [Abstract][Full Text] [Related]
56. Does methotrexate confer a significant advantage over misoprostol alone for early medical abortion? A retrospective analysis of 8678 abortions.
Aldrich T; Winikoff B
BJOG; 2007 May; 114(5):555-62. PubMed ID: 17439563
[TBL] [Abstract][Full Text] [Related]
57. Acceptability of medical abortion with methotrexate and misoprostol.
Creinin MD; Park M
Contraception; 1995 Jul; 52(1):41-4. PubMed ID: 8521713
[TBL] [Abstract][Full Text] [Related]
58. Post-conceptional induction of menses with a single vaginal suppository of (15S)-15-methyl prostaglandin F2 alpha methyl ester.
Scher J; Jeng DY; Kerenyi TD
Prostaglandins; 1980 Sep; 20(3):469-79. PubMed ID: 6252575
[TBL] [Abstract][Full Text] [Related]
59. Medical management of non-viable early first trimester pregnancy.
Autry A; Jacobson G; Sandhu R; Isbill K
Int J Gynaecol Obstet; 1999 Oct; 67(1):9-13. PubMed ID: 10576234
[TBL] [Abstract][Full Text] [Related]
60. Management of missed abortion: comparison of medical treatment with either mifepristone + misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen county, Denmark.
Grønlund A; Grønlund L; Clevin L; Andersen B; Palmgren N; Lidegaard Ø
Acta Obstet Gynecol Scand; 2002 Nov; 81(11):1060-5. PubMed ID: 12421175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
